Filing Details
- Accession Number:
- 0001062993-22-005567
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-24 16:37:01
- Reporting Period:
- 2022-02-23
- Accepted Time:
- 2022-02-24 16:37:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1205922 | Vaccinex Inc. | VCNX | Pharmaceutical Preparations (2834) | 161603202 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1748247 | Van Strydonck, Gerald E. | C/O Vaccinex, Inc. 1895 Mount Hope Avenue Rochester NY 14620 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-23 | 2,000 | $1.30 | 2,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-02-23 | 18,000 | $1.32 | 20,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $14.90 | 2023-03-06 | 7,500 | 7,500 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $13.60 | 2027-09-15 | 6,396 | 6,396 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $5.26 | 2029-03-30 | 2,501 | 2,501 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $7.78 | 2020-05-15 | 7,718 | 7,718 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $5.52 | 2019-06-30 | 2029-06-29 | 2,385 | 2,385 | Direct |
| Common Stock | Stock Option (Right to Buy) | $7.17 | 2019-09-30 | 2029-09-27 | 1,856 | 1,856 | Direct |
| Common Stock | Stock Option (Right to Buy) | $4.85 | 2019-12-31 | 2029-12-28 | 2,737 | 2,737 | Direct |
| Common Stock | Stock Option (Right to Buy) | $3.95 | 2021-05-14 | 15,679 | 15,679 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $2.15 | 2022-05-11 | 28,586 | 28,586 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2023-03-06 | 7,500 | 7,500 | Direct |
| 2027-09-15 | 6,396 | 6,396 | Direct |
| 2029-03-30 | 2,501 | 2,501 | Direct |
| 7,718 | 7,718 | Direct | |
| 2029-06-29 | 2,385 | 2,385 | Direct |
| 2029-09-27 | 1,856 | 1,856 | Direct |
| 2029-12-28 | 2,737 | 2,737 | Direct |
| 15,679 | 15,679 | Direct | |
| 28,586 | 28,586 | Direct |
Footnotes
- Exercisable in full as of the date of this report.
- This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
- This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
- This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
Billionaire Hedge Funds
